Literature DB >> 21513363

Mortality rates and causes of death in children with epilepsy prescribed antiepileptic drugs: a retrospective cohort study using the UK General Practice Research Database.

Ruth Ackers1, Frank M C Besag, Elaine Hughes, Waney Squier, Macey L Murray, Ian C K Wong.   

Abstract

BACKGROUND: Patients with epilepsy, including children, have an increased risk of mortality compared with the general population. Antiepileptic drugs (AEDs) were the most frequent class of drugs reported in a study looking at fatal suspected adverse drug reactions in children in the UK.
OBJECTIVE: The objective of the study was to identify cases and causes of death in a paediatric patient cohort prescribed AEDs with an associated epilepsy diagnosis.
METHODS: This was a retrospective cohort study supplemented with general practitioner-completed questionnaires, post-mortem reports and death certificates. The setting was UK primary care practices contributing to the General Practice Research Database. Participants were children and adolescents aged 0-18 years prescribed AEDs between 1993 and 2005. Causality assessment was undertaken by a consensus panel comprising paediatric specialists in neuropathology, neurology, neuropsychiatry, paediatric epilepsy, pharmacoepidemiology and pharmacy to determine crude mortality rate (CMR) and standardized mortality ratios (SMRs), and the likelihood of an association between AED(s) and the event of death.
RESULTS: There were 6190 subjects in the cohort (contributing 26,890 person-years of data), of whom 151 died. Median age at death was 8.0 years. CMR was 56.2 per 10,000 person-years and the SMR was 22.4 (95% CI 18.9, 26.2). The majority of deceased subjects had severe underlying disorders. Death was attributable to epilepsy in 18 subjects; in 9 the cause of death was sudden unexpected death in epilepsy (SUDEP) [3.3 per 10 000 person-years (95% CI 1.5, 6.4)]. AEDs were probably (n = 2) or possibly (n = 3) associated causally with death in five subjects. Two status epilepticus deaths were associated causally with AED withdrawal.
CONCLUSIONS: Children prescribed AEDs have an increased risk of mortality relative to the general population. Most of the deaths were in children with serious underlying disorders. A small number of SUDEP cases were identified. AEDs are not a major cause of death but in a small proportion of cases, a causal relationship between death and AEDs could not be excluded.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513363     DOI: 10.2165/11588480-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  27 in total

1.  Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs.

Authors:  Ruth Ackers; Macey L Murray; Frank M C Besag; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2007-01-25       Impact factor: 4.335

2.  Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent.

Authors:  I C Wong; G E Mawer; J W Sander
Journal:  BMJ       Date:  1997-06-07

3.  Sudden unexplained death in children with epilepsy.

Authors:  E J Donner; C R Smith; O C Snead
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

Review 4.  Adverse reactions to new anticonvulsant drugs.

Authors:  I C Wong; S D Lhatoo
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

5.  Mortality in childhood-onset epilepsy.

Authors:  Anne T Berg; Shlomo Shinnar; Francine M Testa; Susan R Levy; Susan N Smith; Barbara Beckerman
Journal:  Arch Pediatr Adolesc Med       Date:  2004-12

Review 6.  Pancreatitis associated with valproic acid: a review of the literature.

Authors:  S A Chapman; G P Wacksman; B D Patterson
Journal:  Pharmacotherapy       Date:  2001-12       Impact factor: 4.705

7.  Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United kingdom general practice research database.

Authors:  Paula Louise Thompson; Ruth E Gilbert; Paul F Long; Sonia Saxena; Mike Sharland; Ian Chi Kei Wong
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

8.  Sudden unexpected death in epilepsy: terminology and definitions.

Authors:  L Nashef
Journal:  Epilepsia       Date:  1997-11       Impact factor: 5.864

9.  Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.

Authors:  Suzanne McCarthy; Noel Cranswick; Laura Potts; Eric Taylor; Ian C K Wong
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Valproate-associated pancreatitis.

Authors:  J J Asconapé; J K Penry; F E Dreifuss; A Riela; W Mirza
Journal:  Epilepsia       Date:  1993 Jan-Feb       Impact factor: 5.864

View more
  8 in total

1.  Mortality in children and adolescents prescribed antipsychotic medication: a retrospective cohort study using the UK general practice research database.

Authors:  Fariz A Rani; Patrick Byrne; Noel Cranswick; Macey L Murray; Ian C K Wong
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

Review 2.  The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy.

Authors:  David J Thurman; Giancarlo Logroscino; Ettore Beghi; W Allen Hauser; Dale C Hesdorffer; Charles R Newton; Fulvio Alexandre Scorza; Josemir W Sander; Torbjörn Tomson
Journal:  Epilepsia       Date:  2016-11-26       Impact factor: 5.864

3.  Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  Cynthia Harden; Torbjörn Tomson; David Gloss; Jeffrey Buchhalter; J Helen Cross; Elizabeth Donner; Jacqueline A French; Anthony Gil-Nagel; Dale C Hesdorffer; W Henry Smithson; Mark C Spitz; Thaddeus S Walczak; Josemir W Sander; Philippe Ryvlin
Journal:  Epilepsy Curr       Date:  2017 May-Jun       Impact factor: 7.500

4.  Mortality risks in new-onset childhood epilepsy.

Authors:  Anne T Berg; Katherine Nickels; Elaine C Wirrell; Ada T Geerts; Petra M C Callenbach; Willem F Arts; Christina Rios; Peter R Camfield; Carol S Camfield
Journal:  Pediatrics       Date:  2013-06-10       Impact factor: 7.124

5.  Educational and health outcomes of children and adolescents receiving antiepileptic medication: Scotland-wide record linkage study of 766 244 schoolchildren.

Authors:  Michael Fleming; Catherine A Fitton; Markus F C Steiner; James S McLay; David Clark; Albert King; Daniel F Mackay; Jill P Pell
Journal:  BMC Public Health       Date:  2019-05-17       Impact factor: 3.295

Review 6.  Medication safety research by observational study design.

Authors:  Kim S J Lao; Celine S L Chui; Kenneth K C Man; Wallis C Y Lau; Esther W Chan; Ian C K Wong
Journal:  Int J Clin Pharm       Date:  2016-03-22

Review 7.  Recognizing and preventing epilepsy-related mortality: A call for action.

Authors:  Orrin Devinsky; Tanya Spruill; David Thurman; Daniel Friedman
Journal:  Neurology       Date:  2015-12-16       Impact factor: 9.910

8.  Long-term mortality of patients with West syndrome.

Authors:  Matti Sillanpää; Raili Riikonen; Maiju M Saarinen; Dieter Schmidt
Journal:  Epilepsia Open       Date:  2016-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.